Department of Pediatrics, Division of Infectious Diseases and Immunology, Nationwide Children's Hospital and The Ohio State University, Columbus.
Quality Improvement Services, Nationwide Children's Hospital and The Ohio State University, Columbus.
JAMA Pediatr. 2015 Apr;169(4):324-31. doi: 10.1001/jamapediatrics.2014.3291.
Children with intestinal failure are at high risk for developing central catheter-associated bloodstream infections (CCABSIs) owing to children's chronic dependence on central venous catheters for parenteral nutrition.
To evaluate the effectiveness and safety of the addition of ethanol lock prophylaxis to a best-practice CCABSI prevention bundle on hospital and ambulatory CCABSI rates in children with intestinal failure.
DESIGN, SETTING, AND PARTICIPANTS: Quality improvement and statistical process control analysis that took place at a tertiary care pediatric hospital and patient homes. Participants included children who were 18 years or younger with intestinal failure requiring a central venous catheter.
Central catheter-associated bloodstream infection prevention bundle that included daily ethanol lock prophylaxis.
Central catheter-associated bloodstream infection rates and safety outcomes (central catheter insertions, repairs, and hospitalizations) before (January 1, 2011-January 31, 2012) and after (February 1, 2012-December 31, 2013) ethanol lock prophylaxis bundle implementation.
Twenty-four children with intestinal failure received the ethanol lock prophylaxis CCABSI prevention bundle for a median of 266 days (range, 12-635 days). Rates of CCABSI decreased from 6.99 CCABSIs per 1000 catheter days at baseline to 0.42 CCABSI per 1000 catheter days after ethanol lock prophylaxis bundle implementation, despite an increase in the total number of catheter days. A subset of 14 children who received prolonged ethanol lock prophylaxis (≥3 months) had fewer median (range) central catheter insertions 0 (0-2) vs 3 (0-6); P = .001. The pre-ELP intervention CCABSI rates in this subset was 7.01 per 1000 catheter days vs 0.64 per 1000 catheter days for post-ELP intervention (P = .004). There were no significant differences in the total number of hospital admissions; however, there were fewer hospitalizations for fever and CCABSI (P = .003).
A best-practice CCABSI prevention bundle that included ethanol lock prophylaxis in both the hospital and home was successfully implemented, well tolerated, and demonstrated a significant and sustained reduction in preventable harm in the form of CCABSIs in children with intestinal failure.
由于儿童长期依赖中心静脉导管进行肠外营养,因此患有肠衰竭的儿童发生中心导管相关血流感染(CCABSI)的风险很高。
评估在肠衰竭患儿中,添加乙醇锁预防措施对最佳实践 CCABSI 预防方案包的有效性和安全性,以降低医院和门诊 CCABSI 发生率。
设计、设置和参与者:在三级儿科医院和患者家中进行的质量改进和统计过程控制分析。参与者包括年龄在 18 岁以下、需要中心静脉导管的肠衰竭患儿。
包括每日乙醇锁预防的中心导管相关血流感染预防方案包。
在实施乙醇锁预防方案包之前(2011 年 1 月 1 日至 2012 年 1 月 31 日)和之后(2012 年 2 月 1 日至 2013 年 12 月 31 日),记录中心导管相关血流感染率和安全性结果(中心导管插入、修复和住院)。
24 例肠衰竭患儿接受了乙醇锁预防 CCABSI 预防方案包,中位时间为 266 天(范围 12-635 天)。尽管导管天数总数增加,但 CCABSI 发生率从基线时的每 1000 导管日 6.99 例下降至乙醇锁预防方案包实施后的每 1000 导管日 0.42 例。14 名接受长期乙醇锁预防(≥3 个月)的患儿的中位数(范围)中心导管插入次数更少,分别为 0(0-2)和 3(0-6);P = .001。在该亚组中,前 ELP 干预 CCABSI 率为每 1000 导管日 7.01 例,后 ELP 干预 CCABSI 率为每 1000 导管日 0.64 例(P = .004)。两组患儿的总住院人数无显著差异,但因发热和 CCABSI 的住院人数更少(P = .003)。
在医院和家庭中实施了包含乙醇锁预防的最佳实践 CCABSI 预防方案包,该方案包得到了很好的实施,耐受性良好,并显著且持续地降低了肠衰竭患儿可预防的伤害形式,即 CCABSI。